The immunoengineering field is transforming cancer, autoimmunity, regeneration, and transplantation treatments by combining the diverse and complex fields of engineering and immunology. This symposium will highlight some of the latest advances in immunoengineering with a focus on translational aspects of the field. It is also a celebration of the Johns Hopkins Translational Immunoengineering Center renewal and its accomplishments.
Date and Time
March 4, 2025, from 8:00 am – 1:00 pm ET.
Location and Directions
Chevy Chase Auditorium in the Sheikh Zayed Tower building, Johns Hopkins Hospital
View the campus map or download the Johns Hopkins Find Your Way App to help you navigate the campus.
Keynote Speakers
Robert Seder, MD
Chief, Cellular Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH
Vax-Innate: Improving Therapeutic Cancer Vaccines by Modulating T cells and the Tumor Microenvironment
Michel Sadelain, MD
Inaugural Director of the Columbia Initiative in Cell Engineering and Therapy
Antigen Sensitivity, Logic Gating and Persistence of CAR T cells.
Agenda
Stop at the registration table to check-in, get your badge, and scan the flyer to get the QR code for the agenda.
Jonathan Schneck, MD, PhD
Professor of Pathology, Medicine, and Oncology, Johns Hopkins University
Co-PI, Johns Hopkins Translational Immunoengineering
Biography
Jordan Green, PhD
Professor of Biomedical Engineering, Ophthalmology, Oncology, Neurosurgery, and Materials Science & Engineering, Johns Hopkins University School
Co-PI, Johns Hopkins Translational Immunoengineering
Biography
Landon King, MD
Executive Vice Dean for the Johns Hopkins University School of Medicine
David Marine Professor of Medicine and Biological Chemistry
Biography
T.E. Schlesinger, PhD
Benjamin T. Rome Dean, Whiting School of Engineering
Professor of Electrical and Computer Engineering, Johns Hopkins University
Biography
Denis Wirtz, PhD
Vice Provost for Research at Johns Hopkins University
Theophilus Halley Smoot Professor in the Department of Chemical and Biomolecular Engineering
Biography
Robert Seder, MD
Chief, Cellular Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, NIH
Vax-Innate: Improving Therapeutic Cancer Vaccines by Modulating T Cells and the Tumor Microenvironment
Biography
Si-Sim Kang, MS
PhD Candidate (Jonathan Schneck), Department of Pathology, Johns Hopkins University
Using Nanoparticles as Artificial Antigen Presenting Cells to Activate Human CD4 T Cells for Immunotherapy
Leonard Cheng, BS
PhD Candidate (Hai-Quan Mao and Jordan Green), Department of Biomedical Engineering, Johns Hopkins University
Machine Learning Elucidates Design Features and Accelerates the Development of Lipid Nanoparticles for Cell Type-Preferential Transfection
Jamie Spangler, PhD
William R. Brody Faculty Scholar and Associate Professor of Biomedical Engineering at Johns Hopkins University
Training and Dissemination Co-PI & TR&D 3 Co-PI, Johns Hopkins Translational Immunoengineering
Biography
Jakub Tomala, PhD
Assistant Research Professor , Johns Hopkins Whiting School of Engineering
Cytokine-antibody Single-chain Fusions for Immunotherapy of Cancer and Autoimmune Diseases
Biography
Michel Sadelain, MD
Inaugural Director of the Columbia Initiative in Cell Engineering and Therapy Antigen Sensitivity at Memorial Sloan Kettering Cancer Center
Antigen Sensitivity, Logic Gating, and Persistence of CAR T cells.
Biography
Scott Carmer
Executive Consultant, Biotech
Biography
Ben Larman, PhD
Associate Professor of Pathology, Johns Hopkins University
Biography
Kris Sachsenmeier, PhD
Vice President, Head Of Translational Science, Compass Therapeutics
Biography
Matt Tremblay, PhD
Chief Executive Officer, Blackbird Labs
Biography
Moderators
Stephany Tzeng, PhD
Associate Research Professor, Department of Biomedical Engineering, Johns Hopkins University
TR&D Co-I, Johns Hopkins Translational Immunoengineering
Biography
Drew Pardoll, MD, PhD
Abeloff Professor of Oncology, Medicine, Pathology and Molecular Biology and Genetics, Johns Hopkins University
Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy
Co-PI TR&D 3, Johns Hopkins Translational Immunoengineering
Biography
Supported by Femtobiomed.